Encycle Therapeutics Overview
- Founded
- 2012
- Status
- Acquired/Merged
- Employees
- 6
- Latest Deal Type
- M&A
- Latest Deal Amount
- $80M
Encycle Therapeutics General Information
Description
Developer of drugs designed to exploit a novel synthetic method to generate drug-like cyclic peptides. The company's drugs are generated by several scaffolds that are membrane permeable and orally bioavailable products, such as nacellins which are ideal for targeting protein-protein interactions, enabling patients to get cured from inflammatory bowel disease and other inflammatory disorders.
Contact Information
Website
www.encycletherapeutics.com
Ownership Status
Acquired/Merged
(Operating Subsidiary)
(Operating Subsidiary)
Financing Status
Formerly VC-backed
Primary Office
- 101 College Street
- Suite 314
- Toronto, Ontario M5G 1L7
- Canada
+1 (647) 000-0000
Encycle Therapeutics Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 6. Merger/Acquisition | 23-Oct-2019 | $80M | 00.000 | 0000 | Completed | Generating Revenue |
| 5. Corporate | 01-Nov-2017 | 00000 | 00.000 | Completed | Generating Revenue | |
| 4. Early Stage VC | 30-Sep-2015 | 00.000 | 00.000 | Completed | Startup | |
| 3. Early Stage VC | 16-Jun-2015 | 00000 | 00.000 | Completed | Startup | |
| 2. Grant | 17-Nov-2014 | $2.5M | Completed | Startup | ||
| 1. Early Stage VC | 11-Nov-2014 | $2.5M | $2.5M | Completed | Startup |
Encycle Therapeutics Comparisons
Description
Primary
Industry
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last Financing Details
Developer of drugs designed to exploit a novel synthetic method to generate drug-like cyclic peptides. The company's dru
Drug Discovery
Toronto, Canada
6
As of 2015
00.000
000
0000-00-00
000000&0
00.000
00000000
nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat. Duis aute irure dolor
0000 000000000
Vienna, Austria
00.000
00000000000
00.000
000000 0
ullamco laboris nisi ut aliquip ex ea commodo consequat. Duis aute irure dolor in reprehenderit in v
0000 000000000
South San Francisco, CA
00
As of 0000
00000
0000
0000-00-00
00000000000
00000
Add Comparison
PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.
Request a free trialEncycle Therapeutics Competitors (19)
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| Apeptico | Venture Capital-Backed | Vienna, Austria | 00.000 | 00000000000 | 00.000 | |
| 000000 000000 | Venture Capital-Backed | South San Francisco, CA | 00 | 00000 | 00000000000 | 00000 |
| 0000000 0000000000 | Formerly VC-backed | Cambridge, United Kingdom | 000 | 00000 | 000000000 | 00000 |
| 0000000 0000000000 | Formerly VC-backed | Boston, MA | 0 | 00000 | 000000000 | 00000 |
| 000000 00000000000 | Formerly VC-backed | Boston, MA | 000 | 00000 | 000000 - 000 | 00000 |
Encycle Therapeutics Signals
Growth Rate
0.80%
Weekly
Growth
Growth
Weekly Growth
0.80%, 93rd %ile
-35.5%.
530%
Size Multiple
219x
Median
Size Multiple
219x, 100th %ile
0.00x
0.95x.
413Kx
Key Data Points
Twitter Followers
5.5k
Similarweb Unique Visitors
15.0K
Majestic Referring Domains
314
PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.
Request a free trialEncycle Therapeutics Former Investors (9)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds | Contact Info |
|---|---|---|---|---|---|
| Accel-Rx | Accelerator/Incubator | Minority | 000 0000 | 000000 0 | |
| BDC Capital | Venture Capital | Minority | 000 0000 | 000000 0 | |
| CQDM | Other | Minority | 000 0000 | 000000 0 | |
| MaRS Investment Accelerator Fund | Venture Capital | Minority | 000 0000 | 000000 0 | |
| Merck & Co. | Corporation | 000 0000 | 000000 0 |